Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T19:12:59.182Z.
Calculation as of: 2026-10-06T19:12:59.182Z.
Quote observation: 2026-10-06T19:09:44.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2100d4567e155cb65401b1d64ef1112e8effddeb5d941ccec26242c7dbad22d6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Orchestra BioMed Holdings, Inc.
Market Cap
$351.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$352.09M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$356.12M
Operating Cash Flow Yield
17.07%
TTM Avg
15.02%
3Y Avg
13.56%
5Y Avg
11.99%
Market Cap
$356.90M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$345.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.08M
Operating Cash Flow Yield
N/A
TTM Avg
3.39%
3Y Avg
3.76%
5Y Avg
5.04%
Market Cap
$357.44M
Operating Cash Flow Yield
48.71%
TTM Avg
54.62%
3Y Avg
24.22%
5Y Avg
23.43%
Market Cap
$359.44M
Operating Cash Flow Yield
N/A
TTM Avg
15.24%
3Y Avg
15.24%
5Y Avg
15.24%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | $351.98M | N/A | N/A | N/A | N/A |
| Turn Therapeutics Inc. (TTRX)vs › | $352.09M | N/A | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $356.12M | 17.07% | 15.02% | 13.56% | 11.99% |
| Ocugen, Inc. (OCGN)vs › | $356.10M | N/A | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $356.90M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $345.61M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.08M | N/A | 3.39% | 3.76% | 5.04% |
| Embecta Corp. (EMBC)vs › | $357.44M | 48.71% | 54.62% | 24.22% | 23.43% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.44M | N/A | 15.24% | 15.24% | 15.24% |
| Opus Genetics, Inc. (IRD)vs › | $364.12M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
